How Inclusive Is Digital Inclusion?
To address this question DigiSoc and Ethics@KU Leuven will host an interdisciplinary lunch workshop on 7 May 2026 in Leuven.
News
125 items-
Discover more
-
EMA: adoption of ICH M15 (Step 5)
The European Medicines Agency (EMA) has announced the successful adoption of ICH M15 (Step 5), establishing a harmonized international framework for planning, evaluating, and communicating Model informed Drug Development (MIDD) evidence.
Discover more -
Incorporating Patient Preference Information Across Product Life Cycle
The U.S. Food and Drug Administration (FDA) has released updated guidance aimed at strengthening how patient perspectives are incorporated into medical device decision-making throughout the total product life cycle.
Discover more -
EU Public Consultations Relevant to Our Community
Three important European consultations are currently open for feedback. These initiatives represent key opportunities to help shape policy and regulatory frameworks impacting research, innovation, and healthcare across Europe.
Discover more -
FDA hits first milestone in plan to phase out animal testing
The U.S. Food and Drug Administration (FDA) has reported the successful achievement of its first-year objectives aimed at reducing animal testing in drug development, representing a notable milestone for the in silico medicine community.
Discover more -
In the literature: April 2026 highlights
Discover the recently published papers from our community!
Discover more -
In the literature: May 2026 highlights
Discover the recently published papers from our community!
Discover more -
VPH ready to support Mission Cancer call on Virtual Human Twins
The VPH Society is preparing to contribute to the upcoming HORIZON-MISS-2026-02-CANCER-01 call under the European Commission Mission on Cancer, and invites interested organisations to get in touch for collaboration.
Discover more -
VPH contributes to multiple Horizon Europe proposals and strengthens its service offering
Over the past months, VPH has been actively involved in a number of project proposals, confirming its role as a trusted partner for high-impact, cross-cutting activities.
Discover more -
VPH Best Poster Award 2026
The VPH Best Poster Award honours the best poster presentation by a VPH student member at the VPH 2026 Conference. The winner will receive a certificate and a €350 cash prize.
Discover more -
FDA advances regulatory use of New Approach Methodologies (NAMs)
On 18 March 2026, the Food and Drug Administration (FDA) published a new draft guidance titled "General Considerations for the Use of New Approach Methodologies in Drug Development", marking a significant step toward integrating innovative, non-animal methodologies into regulatory decision-making.
Discover more -
EMA releases the NDSG Workplan 2026–2028 on Data and AI in medicines regulation
On 9 March 2026, the European Medicines Agency (EMA) published the Network Data Steering Group (NDSG) Workplan 2026–2028 outlining a strategic roadmap for strengthening the use of data and AI across the European medicines regulatory network.
Discover more
